Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine

Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but also as an immunogen; with the latter generally n...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Wook-Jin, Yoon, Yeon-Kyung, Park, Ji-Sun, Pansuriya, Ruchirkumar, Seok, Yeong-Jae, Ganapathy, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586335/
https://www.ncbi.nlm.nih.gov/pubmed/34764353
http://dx.doi.org/10.1038/s41598-021-01549-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586335/
https://www.ncbi.nlm.nih.gov/pubmed/34764353
http://dx.doi.org/10.1038/s41598-021-01549-z

Ejemplares similares